Exploration of quantitative MRI-imaging for characterisation of pancreas carcinoma

Phase 1

• Conditions: healthy volunteers; C25.0; Head of pancreas

• Registration Number: DRKS00025747
• Lead Sponsor: Insitut für Diagnostische und Interventionelle Radiologie Uniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Healthy volunteers
Patients diagnosed with pancreatic cancer

Exclusion Criteria

MRI contraindication

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Differences in relaxation times between pancreas tissue and cancer.

Secondary Outcome Measures

Name	Time	Method
Reduced image artifacts and faster acquisition.